Skip to main content
SpringerLink
Log in

Antimalarials increase neutropenia risk in HIV-infected children

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Gasasira AF, Kamya MR, Achan J, Mebrahtu T, Kalyango JN, Ruel T, Charlebois E, Staedke SG, Kekitiinwa A, Rosenthal PJ, Havlir D, Dorsey G.High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda. Clinical Infectious Diseases 46: 985-991, No. 7, 1 Apr 2008

  2. Olliaro P.Disease and drug interactions: treating malaria with artesunate plus amodiaquine in patients also receiving treatment for concomitant HIV infection. Clinical Infectious Diseases 46: 992-993, No. 7, 1 Apr 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Antimalarials increase neutropenia risk in HIV-infected children. React. Wkly. 1197, 3 (2008). https://doi.org/10.2165/00128415-200811970-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200811970-00006

Keywords

Search

Navigation